DEA reschedules Epidiolex, marijuana-derived drug, paving the way for it to hit the market
September 27, 2018 at 10:41 AM EDT
This paves the way GW Pharmaceuticals to start selling the first FDA-approved drug that's derived from cannabis, but stopping short of resclassifying all cannabidiol products.
